Media Contact: Michelle Kirkwood, 703-299-2053 or firstname.lastname@example.org.
The most recent press releases from the American Diabetes Association:
September 28, 2016
American Diabetes Association Applauds FDA’s Approval of the First Hybrid Insulin Delivery System
The American Diabetes Association is pleased with the FDA’s approval today of the first hybrid insulin delivery system. This is a critical step in the development of an artificial pancreas, and an important milestone for people with type 1 diabetes.
September 26, 2016
American Diabetes Association Launches Diabetes Dance Dare, an Online Dance and Donate Campaign
Today, the American Diabetes Association announced the Diabetes Dance Dare to raise awareness about the impact of diabetes and to empower people across the U.S. to get moving. The social media campaign encourages people to record videos of their dances, share them online via Instagram or Twitter, and challenge others to dance and donate to the Association.
September 14, 2016
American Diabetes Association and Google Collaborate to Provide Easy Access to Quality Diabetes Information
The American Diabetes Association (Association) today announced its first collaboration with Google to improve access to quality diabetes information online through the Ask Your Doctor feature in Google’s Knowledge Graph. The initiative, which launched last week, aims to provide frequently asked questions and answers about diabetes treatment, taken directly from the Association’s Standards of Medical Care. The goal is to empower patients with the information needed to speak with their health care providers to effectively manage their diabetes.
August 23, 2016
County-Level Data Reveal Three-Fold Difference in Diabetes Prevalence Across the U.S.
A county-level analysis of diabetes data in the United States reveals wide variations in prevalence across the country, with a three-fold difference in prevalence among counties with the highest and lowest rates.
July 21, 2016
American Diabetes Association Recognizes U.S. Companies and Organizations as New Health Champions
The American Diabetes Association today announced 31 new companies as Health Champions as part of its Wellness Lives Here℠ initiative. This brings the total number of Health Champions nationwide to 191 companies and organizations in 455 locations.
July 19, 2016
American Diabetes Association is a Joint Plaintiff in Lawsuit, Filed Today, to Fight Discrimination by Army Child, Youth & School Services Program
The American Diabetes Association today joined a family in California as the organizational plaintiff in a lawsuit challenging a nationwide policy by the United States Army's Child, Youth & School Services (Army CYSS) program that continues to prevent children with diabetes from participating in Army CYSS programs.
July 18, 2016
American Diabetes Association Celebrates Signing of Pennsylvania School Diabetes Care Law
The American Diabetes Association today celebrates the passage of Pennsylvania school diabetes care legislation ensuring that children living with diabetes have a support system in place that allows them to be medically safe at school and have the same educational opportunity as their peers.
July 13, 2016
Chef'd and American Diabetes Association Announce Collaboration to Create Meal-Kit Options for Americans Living With Diabetes
Chef’d, America’s First and Only Online Meal Store, and the American Diabetes Association today announced the launch of a first-of-its-kind meal-kit delivery partnership aimed to offer a selection of easy-to-prepare, well-balanced meals to the millions of Americans living with or at risk for diabetes.
July 8, 2016
American Diabetes Association Applauds Next Step in Medicare Coverage for National Diabetes Prevention Program
The American Diabetes Association applauds the Obama Administration and, particularly, Health and Human Services (HHS) Secretary Sylvia Mathews Burwell for their continued commitment to providing improved health care and preventive services to Americans with prediabetes.
July 7, 2016
Diabetes Advocates and Experts Join Secretary Burwell for Roundtable on Medicare Coverage of National Diabetes Prevention Program
June 28, 2016
Amaranth Diabetes Foundation Achieves Milestone of $15 Million in Donations to American Diabetes Association Research Foundation
The Amaranth Diabetes Foundation, the philanthropic charity of the Order of the Amaranth, has reached a milestone of $15 million in total contributions since 1979 to the American Diabetes Association Research Foundation. The 2016 donation, in the amount of $542,983, marks 37 years of ADF's financial support for American Diabetes Association research grants.
June 14, 2016
Pioglitazone Decreases Type 2 Diabetes Risk in Stroke Patients with Insulin Resistance
Pioglitazone greatly decreases the risk of developing type 2 diabetes, especially for those who already have prediabetes and/or who have had strokes, according to a study presented at the American Diabetes Association's 76th Scientific Sessions® at the Ernest N. Morial Convention Center in New Orleans.
June 14, 2016
New Diabetes Prevention Program Data Indicates Physical Activity Helps Prevent Type 2 Diabetes, Independent of Weight Loss
Physical activity, independent of weight loss, may help to prevent or delay type 2 diabetes in people who are at high risk for diabetes, according to new follow-up data from the landmark Diabetes Prevention Program (DPP) study, presented today in the President’s Oral Session at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.
June 14, 2016
Bionic Pancreas Reduces Hypoglycemia with Automated Glucagon Delivery
Delivering small doses of glucagon through an automated continuous glucose monitoring system can substantially reduce hypoglycemia (low blood glucose levels) in patients with type 1 diabetes, especially at night, according to a study presented at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.
June 13, 2016
Liraglutide Lowers Risk for Cardiovascular Complications, Kidney Disease and Death in People with Type 2 Diabetes
Liraglutide, a glucose-lowering drug, has been shown to safely and effectively lower the overall risk of heart attack, stroke or cardiovascular death among people with type 2 diabetes at high risk for cardiovascular disease, according to results from the Liraglutide Effect and Action in Diabetes – Evaluation of Cardiovascular Outcome Results (LEADER) trial.
June 13, 2016
Recipients of Prestigious "Pathway to Stop Diabetes" Grants Will Highlight Their Research Progress at the 76th Scientific Sessions
Distinguished grant recipients of the American Diabetes Association's "Pathway to Stop Diabetes" research initiative will present the latest progress in their respective research grants during the Association's 76th Scientific Sessions, June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans.
June 12, 2016
Lifestyle Intervention Achieves Increased Reduction in A1C After Six Months for African Americans with Type 2 Diabetes
A study designed to test the impact of an intensive lifestyle intervention program on lowering blood glucose levels in low-income, African Americans with type 2 diabetes successfully reduced A1C after six months, relative to standard-of-care diabetes education.
June 12, 2016
American Diabetes Association and IBM Watson Health Join Forces to Reimagine How Diabetes is Prevented and Managed
The American Diabetes Association and IBM Watson Health today announced a long-term collaboration to bring together the cognitive computing power of Watson and the Association's vast repository of clinical and research data. The organizations aim to build a first-of-its-kind diabetes advisor for patients and caregivers.
June 11, 2016
Use of an Insulin-Only Bionic Pancreas Effectively Controls Blood Glucose Levels
Use of an insulin-only bionic pancreas effectively controls blood glucose levels, with no difference in episodes of hypoglycemia (low blood glucose levels), compared to a bihormonal (insulin plus glucagon) bionic pancreas, when both insulin-only and bihormonal configurations used a target blood sugar of 130 mg/dl, according to a study presented at the American Diabetes Association's 76th Scientific Sessions at the Ernest N. Morial Convention Center in New Orleans.
June 11, 2016
Beyond A1C—Why Quality of Life Matters
Health-related quality of life (HRQOL) is an important area of investigation that has gained increasing recognition and is a critical element of diabetes research, treatment and care, according to experts at the Symposium, "Beyond A1C—Why Quality of Life Matters," presented on June 11, 2016, during the American Diabetes Association's 76th Scientific Sessions, June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans.